West Penn Allegheny Clinical Trial Tests New Barrett’s Esophagus Treatment

//West Penn Allegheny Clinical Trial Tests New Barrett’s Esophagus Treatment

West Penn Allegheny Health System researchers are investigating whether a new ablation technology can provide safer and more effective treatment for patients with Barrett’s Esophagus, a condition associated with gastroesophageal reflux disease (GERD) that can progress to esophageal cancer if left untreated.

Click here for the full story.

2017-08-28T19:48:57+00:00